Novo Integrated Sciences Inc
Change company Symbol lookup
Select an option...
NVOS Novo Integrated Sciences Inc
RPRX Royalty Pharma PLC
NUE Nucor Corp
MORN Morningstar Inc
TOP TOP Financial Group Ltd
VEEV Veeva Systems Inc
ETY Eaton Vance Tax-Managed Diversified Equity Income Fund
FDX FedEx Corp
TARO Taro Pharmaceutical Industries Ltd
TIO Tingo Group Inc
Go

*Nasdaq FSI: *Deficient and Delinquent: Issuer Failed to Meet NASDAQ Continued Listing Requirements, and Missed Regulatory Filing Deadline

Health Care : Health Care Providers & Services | Small Cap Value

Company profile

Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

Postmarket

Last Trade: Delayed
$0.1242

Change Since Close Change Since Close Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.: 0.0017 (1.39%)

Bid: --

Ask: --

B/A Size: --

Market Hours

Closing Price: $0.1225

Day's Change: -0.0135 (-9.93%)

Bid close: --

Ask close: --

B/A Size: --

Day's High: 0.1372

Day's Low: 0.12

Volume (Above Average) Volume: 8,286,232 10-day average volume: 7,341,328: 8,286,232

May 26, 2023
5:00 pm ET	Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services...(BusinessWire)
May 24, 2023
4:30 pm ET	Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services...(BusinessWire)
April 27, 2023
8:00 am ET	Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000 --Note has a non-compounding yield of 1.52% (zero coupon) per annum Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the "Company" or "Novo"), today announced the issuance of an unsecured 15-year $70,000,000 promissory note with RC Consulting LLC in...(BusinessWire)
April 03, 2023
5:20 pm ET	Novo Integrated Sciences Reports Fiscal Full Year 2022 Financial Results Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints providing...(BusinessWire)
March 24, 2023
9:00 am ET	Novo Integrated Sciences Provides Update on Certain Current Actions and Events Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the "Company" or "Novo"), today provides an update with respect to certain actions and events, as follows: As previously reported, on December 23, 2022, Novo entered into a Share Purchase Agreement (the...(BusinessWire)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Postmarket

Change Since Close

Market Hours